116 related articles for article (PubMed ID: 29143774)
21. The C-terminus of viral vascular endothelial growth factor-E partially blocks binding to VEGF receptor-1.
Inder MK; Wise LM; Fleming SB; Mercer AA
FEBS J; 2008 Jan; 275(1):207-17. PubMed ID: 18076652
[TBL] [Abstract][Full Text] [Related]
22. The basis for the distinct biological activities of vascular endothelial growth factor receptor-1 ligands.
Anisimov A; Leppänen VM; Tvorogov D; Zarkada G; Jeltsch M; Holopainen T; Kaijalainen S; Alitalo K
Sci Signal; 2013 Jul; 6(282):ra52. PubMed ID: 23821770
[TBL] [Abstract][Full Text] [Related]
23. Iterative Nonproteinogenic Residue Incorporation Yields α/β-Peptides with a Helix-Loop-Helix Tertiary Structure and High Affinity for VEGF.
Checco JW; Gellman SH
Chembiochem; 2017 Feb; 18(3):291-299. PubMed ID: 27897370
[TBL] [Abstract][Full Text] [Related]
24. Extending foldamer design beyond α-helix mimicry: α/β-peptide inhibitors of vascular endothelial growth factor signaling.
Haase HS; Peterson-Kaufman KJ; Lan Levengood SK; Checco JW; Murphy WL; Gellman SH
J Am Chem Soc; 2012 May; 134(18):7652-5. PubMed ID: 22548447
[TBL] [Abstract][Full Text] [Related]
25. Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis.
Binétruy-Tournaire R; Demangel C; Malavaud B; Vassy R; Rouyre S; Kraemer M; Plouët J; Derbin C; Perret G; Mazié JC
EMBO J; 2000 Apr; 19(7):1525-33. PubMed ID: 10747021
[TBL] [Abstract][Full Text] [Related]
26. Identification of high-affinity VEGFR3-binding peptides through a phage-displayed random peptide library.
Shi LF; Wu Y; Li CY
J Gynecol Oncol; 2015 Oct; 26(4):327-35. PubMed ID: 26197772
[TBL] [Abstract][Full Text] [Related]
27. Unveiling a VEGF-mimetic peptide sequence in the IQGAP1 protein.
Capasso D; Di Gaetano S; Celentano V; Diana D; Festa L; Di Stasi R; De Rosa L; Fattorusso R; D'Andrea LD
Mol Biosyst; 2017 Jul; 13(8):1619-1629. PubMed ID: 28685787
[TBL] [Abstract][Full Text] [Related]
28. Rational design, structure, and biological evaluation of cyclic peptides mimicking the vascular endothelial growth factor.
Goncalves V; Gautier B; Coric P; Bouaziz S; Lenoir C; Garbay C; Vidal M; Inguimbert N
J Med Chem; 2007 Oct; 50(21):5135-46. PubMed ID: 17900101
[TBL] [Abstract][Full Text] [Related]
29. Design and synthesis of C-terminal modified cyclic peptides as VEGFR1 antagonists.
Wang L; Gagey-Eilstein N; Broussy S; Reille-Seroussi M; Huguenot F; Vidal M; Liu WQ
Molecules; 2014 Sep; 19(10):15391-407. PubMed ID: 25264829
[TBL] [Abstract][Full Text] [Related]
30. Coordinate expression of vascular endothelial growth factor receptor-1 (flt-1) and its ligand suggests a paracrine regulation of murine vascular development.
Breier G; Clauss M; Risau W
Dev Dyn; 1995 Nov; 204(3):228-39. PubMed ID: 8573716
[TBL] [Abstract][Full Text] [Related]
31. Interaction of Some Amino-Nitrile Derivatives with Vascular Endothelial Growth Factor Receptor 1 (VEGFR1) Using a Theoretical Model.
Figueroa-Valverde L; Díaz-Cedillo F; Rosas-Nexticapa M; Alvarez-Ramirez M; Mateu-Armad MV; López-Ramos M; López-Gutierrez T
Drug Res (Stuttg); 2023 Jul; 73(6):355-364. PubMed ID: 37172939
[TBL] [Abstract][Full Text] [Related]
32. Investigating the differential activation of vascular endothelial growth factor (VEGF) receptors.
Horta BA; Sodero AC; de Alencastro RB
J Mol Graph Model; 2009 Oct; 28(3):287-96. PubMed ID: 19734078
[TBL] [Abstract][Full Text] [Related]
33. The development of peptide-based tools for the analysis of angiogenesis.
Fedorova A; Zobel K; Gill HS; Ogasawara A; Flores JE; Tinianow JN; Vanderbilt AN; Wu P; Meng YG; Williams SP; Wiesmann C; Murray J; Marik J; Deshayes K
Chem Biol; 2011 Jul; 18(7):839-45. PubMed ID: 21802005
[TBL] [Abstract][Full Text] [Related]
34. VEGF165b Modulates Endothelial VEGFR1-STAT3 Signaling Pathway and Angiogenesis in Human and Experimental Peripheral Arterial Disease.
Ganta VC; Choi M; Kutateladze A; Annex BH
Circ Res; 2017 Jan; 120(2):282-295. PubMed ID: 27974423
[TBL] [Abstract][Full Text] [Related]
35. New Class of Drug Modalities: Directed Evolution of a De Novo Designed Helix-Loop-Helix Peptide to Bind VEGF for Tumor Growth Inhibition.
Michigami M; Ramanayake Mudiyanselage TMR; Suzuki M; Ishizako H; Notsu K; Sugiura K; Fujii I
ACS Chem Biol; 2022 Mar; 17(3):647-653. PubMed ID: 35176860
[TBL] [Abstract][Full Text] [Related]
36. Targeting VEGF receptors with non-neutralizing cyclopeptides for imaging applications.
Calvanese L; Caporale A; Focà G; Iaccarino E; Sandomenico A; Doti N; Apicella I; Incisivo GM; De Falco S; Falcigno L; D'Auria G; Ruvo M
Amino Acids; 2018 Feb; 50(2):321-329. PubMed ID: 29198078
[TBL] [Abstract][Full Text] [Related]
37. Targeting angiogenesis: structural characterization and biological properties of a de novo engineered VEGF mimicking peptide.
D'Andrea LD; Iaccarino G; Fattorusso R; Sorriento D; Carannante C; Capasso D; Trimarco B; Pedone C
Proc Natl Acad Sci U S A; 2005 Oct; 102(40):14215-20. PubMed ID: 16186493
[TBL] [Abstract][Full Text] [Related]
38. VEGF-A165 induces human aortic smooth muscle cell migration by activating neuropilin-1-VEGFR1-PI3K axis.
Banerjee S; Mehta S; Haque I; Sengupta K; Dhar K; Kambhampati S; Van Veldhuizen PJ; Banerjee SK
Biochemistry; 2008 Mar; 47(11):3345-51. PubMed ID: 18284215
[TBL] [Abstract][Full Text] [Related]
39. Dimerization of VEGF receptors and implications for signal transduction: a computational study.
Mac Gabhann F; Popel AS
Biophys Chem; 2007 Jul; 128(2-3):125-39. PubMed ID: 17442480
[TBL] [Abstract][Full Text] [Related]
40. Suppression of tumor growth and metastasis by a VEGFR-1 antagonizing peptide identified from a phage display library.
An P; Lei H; Zhang J; Song S; He L; Jin G; Liu X; Wu J; Meng L; Liu M; Shou C
Int J Cancer; 2004 Aug; 111(2):165-73. PubMed ID: 15197767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
